News

P&G said that Actonel (risedronate sodium tablets), a therapy proven to reduce the risk of both vertebral and nonvertebral fractures in postmenopausal women with osteoporosis, will soon be

<p>The judge found that the securities action should be dismissed because all of the plaintiffs&#0039; claims were time-barred under the applicable statutes of limitations.<br /><br />The class action

Reclast, which is marketed as Aclasta in some countries, is the first approved treatment for Paget’s disease patients to be given as a single-dose infusion compared to current

The study compared a 40mg dose of Copaxone given daily to the currently approved Copaxone 20mg dose. It was also designed to test the safety and tolerability of

Amgen had already said there was a higher death rate in preliminary data released in January. The overall number of deaths was greater in the Aranesp group at

The trial was designed to assess efficacy and safety with two doses of rotigotine, a dopamine agonist formulated as a patch for once-daily administration, in subjects with advanced

The phase I trial was conducted in 12 patients who underwent stereotactic neurosurgery to deliver the product, CERE-120, into their putamen, a region of the brain affected by

The trial is designed to establish the feasibility, safety and preliminary efficacy of vaccination in patients with recurrent, high-grade glioma, a fatal disease. Findings from a group of

The lawsuit was originally filed in August 2006 by Genzyme Corporation against Cytochroma, Proventiv Therapeutics LLC and three former Bone Care International employees. The complaint alleged misappropriation of